Regional Variations In Alirocumab Dosing Patterns During An Open-Label Extension Study In Patients With Heterozygous Familial Hypercholesterolaemia. (August 2019) - Langslet, G.; Hovingh, G.K.; Guyton, J.R.; Baccara-Dinet, M.T.; Letierce, A.; Manvelian, G.; Farnier, M.